Exertional rhabdomyolysis in athletes requires prompt diagnosis via history, physical, and serology, and foundational treatment with rest and hydration.
Answers are grounded in this paper and cite their sources.
Supports vigilance in athletes; leaves open need for prospective studies on prevention.
CONTEXT: Exertional rhabdomyolysis is a relatively uncommon but potentially fatal condition affecting athletes that requires prompt recognition and appropriate management. EVIDENCE ACQUISITION: A search of the PubMed database from 2003 to 2013 using the term exertional rhabdomyolysis was performed. Further evaluation of the bibliographies of articles expanded the evidence. STUDY DESIGN: Clinical review. LEVEL OF EVIDENCE: Level 3. RESULTS: Exertional rhabdomyolysis (ER) is a relatively uncommon condition with an incidence of approximately 29.9 per 100,000 patient years but can have very serious consequences of muscle ischemia, cardiac arrhythmia, and death. The athlete will have pain, weakness, and swelling in the muscles affected as well as significantly elevated levels of creatine kinase (CK). Hydration is the foundation for any athlete with ER; management can also include dialysis or surgery. Stratifying the athlete into high- or low-risk categories can determine if further workup is warranted. CONCLUSION: Exertional rhabdomyolysis evaluation requires a history, physical examination, and serology for definitive diagnosis. Treatment modalities should include rest and hydration. Return to play and future workup should be determined by the risk stratification of the athlete. STRENGTH-OF-RECOMMENDATION TAXONOMY SORT: C.
No takes yet. Share an insight, caveat, or question.
Tietze et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: